| Product Name |
MF |
CAS |
Details |
| 3-Cyanoumbelliferone |
C10H5NO3 |
19088-73-4 |
|
| 2-[(2,6-Dichlorophenyl)amino]-benzeneacetic Acid 1- Methylethyl Ester |
C17H17Cl2NO2 |
66370-79-4 |
|
| Diazoxide impurity-8 |
C7H5ClN2O3S |
5800-59-9 |
|
| Coumarin-6-carboxaldehyde |
C10H6O3 |
51690-26-7 |
|
| 1,3-bis(1-phenylvinyl)benzene; 1,3-Bis[(phenyl)-ethenyl]-benzene |
C22H18 |
34241-86-6 |
|
| Methyl (1RS)-5-benzoyl-2,3-dihydro-1H-pyrrolizine-1- carboxylate |
C16H15NO3 |
80965-09-9 |
|
| (R)-N,N-Dimethyl-3-(naphthalen-1-yloxy)-1- phenylpropan-1-amine hydrochloride |
C21H24ClNO |
156453-51-9 |
|
| 1-C-[4-Chloro-3-[(4-Ethoxyphenyl)methyl]phenyl]-D- glucitol;(2S,3R,4R)-1-(4-chloro-3-(4- ethoxybenzyl)phenyl)hexane-1,2,3,4,5,6-hexaol;(2S,3R,4R,5R)-1-(4-chloro-3-(4-ethoxybenzyl)phenyl)hexane-1,2,3,4,5,6-hexaol |
C21H27ClO7 |
2100872-88-4 |
|
| 4-Benzylamino-7-nitrobenzofurazan |
C13H10N4O3 |
18378-20-6 |
|
| Propan-2-yl (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E)-3- oxo-4-[3-(trifluoromethyl) phenoxy]but-1- enyl]cyclopentyl]hept-5-enoate |
C26H33F3O6 |
404830-45-1 |
|
| 2-(5-bromoquinoxalin-6-yl)guanidine |
C9H8BrN5 |
168329-48-4 |
|
| 5-[4'-(Azidomethyl)[1,1'-biphenyl]-2-yl]-2H-tetrazole |
C14H11N7 |
152708-24-2 |
|
| 5-Thiazole boronic acid MIDA ester |
|
1357387-30-4 |
|
| 6-NITROINDAN-1-ONE |
C9H7NO3 |
24623-24-3 |
|
| 3-Ethylphenacyl bromide |
C10H11BrO |
152074-06-1 |
|
| 2,6-Dibromoquinone-4-chloroimide |
C6H2Br2ClNO |
537-45-1 |
|
| N-[[(5S)-2-Oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5- oxazolidinyl]methyl]-2-thiophenecarboxamide |
C19H19N3O5S |
1415566-28-7 |
|
| N-[[(5S)-2-Oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3- oxazolidin-5-yl]methyl]acetamide |
C16H19N3O5 |
1429334-00-8 |
|
| METHYL 3-BROMO-5-METHOXY-2-METHYLBENZOATE |
C10H11BrO3 |
13979-62-9 |
|
| 7,8-Dichloro-3-Methyl-2H-1,2,4-Benzothiadiazine-1,1-Dioxide |
C8H6Cl2N2O2S |
31365-86-3 |
|
| (S)-benzyl 2-aminopropylcarbamate |
C11H16N2O2 |
934660-64-7 |
|
| 3-Aminocoumarin |
C9H7NO2 |
1635-31-0 |
|
| (S)-5-Chloro-6-methoxy-α-methyl-2-naphthaleneacetic Acid |
C14H13ClO3 |
89617-86-7 |
|
| GLutaconate |
C7H10O5 |
13192-04-6 |
|
| cyclopentyl N-[3-[[2-methoxy-4-[(4-methylphenyl)sulfonylcarbamoyl]phenyl]methyl]-1- methylindol-5-yl]carbamate |
C31H33N3O6S |
1159195-70-6 |
|
| N-(3-((3-Cyclopropyl-1-(2-fluoro-4-iodophenyl)-6,8-dimethyl-2,4,7-trioxo-1,2,3,4,7,8-hexahydropyrido[2,3-d]pyrimidin-5-yl)amino)phenyl)acetamide |
C26H23FIN5O4 |
871700-25-3 |
|
| 5-Benzoyl-1-methoxy-2,3-dihydro-1H-pyrrolizine-1- carboxylic acid |
C16H15NO4 |
1391053-45-4 |
|
| 3-BROMO-5-METHOXY ANILINE |
C7H8BrNO |
16618-68-1 |
|
| N-Methyl-2-(4-methylpiperazin-1-yl)-N-(4-nitrophenyl)acetamide |
C14H20N4O3 |
1139453-98-7 |
|
| Carfilzomib |
C40H57N5O7 |
868540-17-4 |
|
| tert-Butyl 2-oxa-6-azaspiro[3.5]nonane-6-carboxylate |
C12H21NO3 |
1245816-29-8 |
|
| 6,9-Dichloro-2-Methoxyacridine |
C14H9Cl2NO |
86-38-4 |
|
| 2'-(methylthio)acetophenone |
C9H10OS |
1441-97-0 |
|
| 2-[(11Z)-11-[3-(Dimethylamino) propylidene]-6H- benzo[c][1]benzoxepin-2-yl]acetaldehyde; (Olopatadine Carbaldehyde) |
C21H23NO2 |
1376615-97-2 |
|
| 4-((2-Methoxyphenoxy) methyl)-1,3-dioxolan-2-one |
C11H12O5 |
2049-21-0 |
|
| Dimethyl 1,2,4,5-tetrazine-3,6-dicarboxylate |
C6H6N4O4 |
2166-14-5 |
|
| Risperidone EP Impurity M / Paliperidone USP Related Compound B |
C12H14ClFN2O |
84163-13-3 |
|
| 2,4-Dinitrobenzoic acid |
C7H4N2O6 |
610-30-0 |
|
| 4-(2-aminoethyl)benzonitrile hydrochloride |
C9H11ClN2 |
167762-80-3 |
|
| Boc-2-aminobenzoic acid |
C12H15NO4 |
68790-38-5 |
|
| 8-Bromo-2-methylquinoline |
C10H8BrN |
61047-43-6 |
|
| 4-(chloromethyl)thiazole hydrochloride |
C4H5Cl2NS |
7709-58-2 |
|
| Gedunin |
C28H34O7 |
2753-30-2 |
|
| (2E,4E)-N-Isobutyldecadienamide (Pellitorine) |
C14H25NO |
18836-52-7 |
|
| Methyl 7-(3-hydroxy-5-oxocyclopenten-1-yl)heptanoate. |
C13H20O4 |
40098-26-8 |
|
| 2,2-diphenyl-2-[(3S)-pyrrolidin-3- yl]acetonitrile;hydrobromide |
C18H19BrN2 |
194602-27-2 |
|
| Methyl 3- Bromo-5-Hydroxybenzoate |
C8H7BrO3 |
192810-12-1 |
|
| 2,3-Dihydro-1-oxo-1H-indene-4-carbonitrile |
C10H7NO |
60899-34-5 |
|
| 4-Methylumbelliferyl nonanoate |
C19H24O4 |
18319-93-2 |
|
| 2,1,3-Benzoxadiazole-5-carboxaldehyde |
C7H4N2O2 |
32863-33-5 |
|
| 2-Chloro-N-(3-chloro-2-methylphenyl)nicotinamide |
C13H10Cl2N2O |
57841-61-9 |
|
| Isopropyl (Z)-7-((1S,2S,3S,5R)-3,5-Dihydroxy-2-((S)-3- hydroxy-5-phenylpentyl)cyclopentyl)hept-5-enoate |
C26H40O5 |
130209-82-4 |
|
| 4-[[5-[[(Cyclopentyloxy)carbonyl]amino]-1-methyl-1H- indol-3-yl]methyl]-3-methoxybenzoic Acid |
C24H26N2O5 |
107754-20-1 |
|
| trans-4-(6,8-Dibromo-1,4-dihydroquinazolin-3(2H)- yl)cyclohexanol |
C14H18Br2N2O |
18683-95-9 |
|
| 1-Ethyl-1H-indole |
C10H11N |
10604-59-8 |
|
| 7-Deacetylgedunin |
C26H32O6 |
10314-90-6 |
|
| 1-(4-chlorophenyl)-2-phenylethan-1-one |
C14H11ClO |
1889-71-0 |
|
| 1-Methyl-1H-indene |
C10H10 |
767-59-9 |
|
| 4-[((2R)-Hydroxy-3-phthalimido)propylamine]phenyl-3- morpholinone |
C21H21N3O5 |
446292-07-5 |
|
| 1-[[[(1R)-1-[3-[(1E)-2-(7-Chloro-2- quinolinyl)ethenyl]phenyl]-3-[2-(1- methylethenyl)phenyl]propyl]thio]methyl]cyclopropane acetic Acid |
C35H34ClNO2S |
918972-54-0 |
|
| (S)-(+)-Abscisic acid-d6 |
C15H20O4 |
721948-65-8 |
|
| 4,6-DICHLORO-2-(METHYLSULFANYL)-5-NITROPYRIMIDINE |
C5H3Cl2N3O2S |
1979-96-0 |
|
| Hydroxy chloroquine Imp E |
C14H17ClN2O |
10500-64-8 |
|
| 4-bromo-2-methylbutyl acetate |
C7H13BrO2 |
56761-59-2 |
|
| 1-Hydroxycyclopentanecarboxylic acid |
C6H10O3 |
16841-19-3 |
|
| 6-methyl-1,2,3,4-tetrahydroquinoline |
C10H13N |
91-61-2 |
|
| 2-CHLORO-BENZOTHIAZOL-6-OL |
C7H4ClNOS |
2591-16-4 |
|
| 6-[2-(3,4-Dihydro-4,4-dimethyl-2H-1-benzothiopyran-6- yl)ethynyl]-3-pyridinecarboxylic Acid |
C19H17NO2S |
118292-41-4 |
|
| Nimbolide |
C27H30O7 |
25990-37-8 |
|
| 4-(Ethylaminomethyl)pyridine |
C8H12N2 |
33403-97-3 |
|
| 5’-Bromo-3’-chloro-2’-hydroxyacetophenone |
C8H6BrClO2 |
59443-15-1 |
|
| 5-Bromo-1H-pyrazolo[3,4-b]pyridine |
C6H4BrN3 |
875781-17-2 |
|
| (5Z)-7-((1R,2R,3R,5R)-3,5-Dihydroxy-2-((S,E)-3-hydroxy- 5-phenylpent-1-enyl)cyclopentyl)hept-5-enoic acid |
C23H32O5 |
2095712-81-3 |
|
| 2-Bromo-5-hydroxybenzaldehyde |
C7H5BrO2 |
2973-80-0 |
|
| 6-chloroisoquinoline |
C9H6ClN |
62882-02-4 |
|
| Methy N (5-propoxy-1H-benzo[d]imidazol-2- ylcarbamate |
C12H15N3O3 |
20559-55-1 |
|
| 5-(3-Fluorophenyl)-2-methylpyridine |
C12H10FN |
713143-67-0 |
|
| 2',5-Dichloro-2-hydroxybenzophenone |
C13H8Cl2O2 |
61785-35-1 |
|
| N-Boc-nortropinone |
C12H19NO3 |
185099-67-6 |
|
| (+)-abscisic acid beta-D-glucopyranosyl ester / (+)-(S)-ABA-beta-GE |
C21H30O9 |
21414-42-6 |
|
| 4,4'-(((Carbonylbis(azanediyl))bis(3-fluoro-4,1- phenylene))bis(oxy))bis(N-methylpicolinamide) |
C27H22F2N6O5 |
2438857-80-6 |
|
| 2-(3, 4-Dimethoxy-phenyl) 3-methyl-1-but-2enenitrile |
C13H15NO2 |
20850-47-9 |
|
| Alfa-Bromovalerophenone |
C11H13BrO |
49851-31-2 |
|
| (5Z)-Methyl 7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((S,E)-3- hydroxy-5-phenylpent-1-enyl)cyclopentyl)hept-5- enoate; (Bimatoprost acid methyl ester) |
C24H34O5 |
38315-47-8 |
|
| 2,4-Dichloro-5-(chlorosulfonyl)benzoic acid |
C7H3Cl3O4S |
3740-18-9 |
|
| Ethyl 2-(4-isobutylphenyl)propionate, |
C15H22O2 |
41283-72-1 |
|
| Glimepiride impurity-1 |
C16H20N2O2 |
247098-18-6 |
|
| N-(5-(2-(Benzyl(1-(4-methoxyphenyl)propan-2- yl)amino)-1-hydroxyethyl)-2-hydroxyphenyl)formamide |
C26H30N2O4 |
2514947-17-0 |
|
| N-Methyl-2-nitrobenzenesulfonamide |
C7H8N2O4S |
23530-40-7 |
|
| Clopidogrel Metabolite H4 |
C16H18ClNO4S |
317322-48-8 |
|
| Methyl 5-(diphenylphosphoryl)pentanoate |
C18H21O3P |
146964-27-4 |
|
| 4-(3,5-Dinitrophenyl) morpholin-3-one |
C10H9N3O6 |
2138262-09-4 |
|
| Palifosfamide |
C4H11Cl2N2O2P |
31645-39-3 |
|
| 7-Hydroxy-4-(trifluoromethyl)coumarin |
C10H5F3O3 |
575-03-1 |
|
| 1-(2-chloropyridin-3-yl)ethanone |
C7H6ClNO |
55676-21-6 |
|
| 4-Methylumbelliferyl butyrate |
C14H14O4 |
17695-46-4 |
|
| 4-Methylumbelliferyl octanoate |
C18H22O4 |
20671-66-3 |
|
| 4,6-Dibenzylresorcinol |
C20H14O4 |
3088-15-1 |
|
| Ethyl Phenyl Sulfone |
C8H10O2S |
599-70-2 |
|
| 2-Amino-5-chloro pyridine |
C5H5ClN2 |
1072-98-6 |
|
